Introduction {#Sec1}
============

Surgical correction of aortic coarctation (CoAo) has been successfully performed for over half of the century. Life expectancy remains to be reduced in patients with this congenital heart disease even after successful repair. The main predictors of unfavorable prognosis in that group of patients are arterial hypertension (AH) with subsequent end-organ damage, and an inclination for development of early atherosclerosis \[[@CR1]--[@CR8]\]. The pathophysiology of hypertension that occurs after coarctation repair is still a matter of debate.

Despite successful removal of residual stenosis in the descending aorta (AoD), hypertension is still present in 30--50% of patients, which suggests that CoAo might not be the simple mechanical obstruction of the main artery but more likely a widespread anomaly of the cardiovascular system \[[@CR3], [@CR4], [@CR8], [@CR10], [@CR11]\]. At the same time most of the available data suggests that prognosis is strongly affected by the age at the surgery; AH is less frequent in patients who have undergone coarctation repair in infancy \[[@CR5], [@CR7], [@CR8], [@CR12]--[@CR16]\]. Many researchers point out that early detection and treatment of stenosis of the AoD is associated with better outcomes, since this condition plays a significant role in the pathway leading to AH \[[@CR5], [@CR17], [@CR18]\]. Functional and histopathological studies proved increased stiffness of the precoarctation part of the aorta \[[@CR19], [@CR20]\]. According to the majority of publications, this phenomenon forms the basis for complex interactions present in CoAo---functional abnormalities in vascular reactivity and baroreceptor-reflex function, as well as irreversible arterial remodeling---all leading to hypertension in the studied population \[[@CR3], [@CR5], [@CR21]\]. Elucidation of potential mechanisms underlying vascular remodeling, representing increased vascular stiffness and altered reactivity in CoAo, brings us closer in understanding the pathophysiology of hypertension in those patients. It is justified, in our opinion, to carry out the analysis of significance of residual gradient across AoD for vascular remodeling and the influence exerted by the age at intervention.

The aim of the study was to evaluate arterial stiffness and function in adult patients after coarctation repair, in relation to residual gradient across AoD as well as age at the operation.

Materials and methods {#Sec2}
=====================

The study population consisted of 85 coarctation-repaired patients (53 males) aged 19--64 years (mean 34.6 ± 10.3 years) who had undergone operation at the age of 0.5--34 years (10.9 ± 8.2 years), cared by our adult congenital heart disease outpatient clinic. The control group consisted of 30 healthy individuals (18 males) aged 24--48 (33.6 ± 8.2 years). Most patients in the study group---74 (87%) had undergone Dacron patch repair by the same cardiac surgeon; 4 (5%) had undergone subclavian flap aortoplasty, 7 (8%)---end-to-end anastomosis. Two patients received aortic prosthetic valve (St. Jude Medical). Nine patients had undergone reoperation due to restenosis of the AoD, two patients had received non-invasive treatment of recoarctation, another one had undergone stent-graft implantation into the AoD due to aneurysm. The following congenital heart diseases were additionally diagnosed: bicuspid aortic valve without functional abnormality (*n* = 25, 29.4%), surgically repaired ventrivular septal defect (*n* = 6, 7.1%), occluded persistent arterial duct (*n* = 5, 5.9%), and trivial mitral insufficiency (*n* = 21, 24.7%).

In order to avoid confounding factors which might influence the vascular parameters, the following exclusion criteria were established: acute and chronic inflammatory diseases (in the preceding 3 months), underlying malignancies, cigarette smoking within 12 h before the examination, diabetes mellitus. The investigators performing the assessment of the peripheral and central vessel parameters were blinded to results of the echocardiographic examination.

Clinical characteristics of the study population, including separately demographic and biochemical data for normotensive patients, are presented in Table [1](#Tab1){ref-type="table"}.Table 1Baseline characteristics of the study population and the control groupCoAo (*N* = 85)CoAo AH(−)\
(*N* = 47)Controls\
(*N* = 30)*p* CoAo versus controls*p*CoAo AH(−) versus controlsMale:female53:3230:1718:120.990.81Age (years), mean ± SD (median; range)34.6 ± 10.3 (33; 18--64)33.7 ± 8.2 (33; 18--60)33.6 ± 8.2 (32; 18--61)0.80.92Age at surgery (years)10.9 ± 8.210.8 ± 7.6------Smokers (current)6 (7%)4 (8%)2 (6.5%)0.610.46BMI (kg/m^2^)25.3 ± 3.325.4 ± 3.324.5 ± 3.10.090.08Height (cm)171.4 ± 9.2169.6 ± 9.7173.8 ± 9.60.490.46Weight (kg)74.6 ± 11.873.2 ± 12.571.8 ± 13.80.670.57Bicuspid aortic valve25 (29%)13 (28%)------Glucose (mmol/l)5.2 ± 0.85.2 ± 0.75.2 ± 0.20.10.14Creatinine (umol/l)74.8 ± 12.872.9 ± 11.275.4 ± 8.90.320.41Total cholesterol (mmol/l)5.3 ± 1.05.2 ± 0.85.4 ± 0.90.90.85LDL-cholesterol (mmol/l)3.0 ± 0.62.9 ± 0.73.0 ± 0.40.80.99HDL-cholesterol (mmol/l)1.4 ± 0.31.4 ± 0.31.3 ± 0.20.790.84Triglycerides (mmol/l)1.4 ± 0.41.3 ± 0.51.3 ± 0.60.80.67*BMI* body mass index

A cuff sphygmomanometer was used to measure blood pressure at rest in all participants. Arterial hypertension was recognised if the values of blood pressure exceeded 140/90 mmHg, or a report of a prior diagnosis of hypertension and current antihypertensive treatment, in accordance with the guidelines established in 2007 by the European Society of Hypertension and the European Society of Cardiology \[[@CR15]\]. The study involved both patients on antihypertensive therapy and patients from whom antihypertensive therapy was withdrawn for at least 48 h before the study \[[@CR22]\].

Echocardiographic examination was performed using Vivid 7 (GE Healthcare) with 2.5 MHz probe in 2D, M and Doppler modes. The single investigator evaluated cardiac anatomy and left ventricular systemic function (Simpson biplane method), normal systolic function was a criterion for inclusion in the study. The severity of residual stenosis of the AoD was determined by evaluation of the suprasternal notch. Restenosis was diagnosed when the AoD pressure gradient was equal to or greater than 20 mmHg and rest arm-leg systolic blood pressure gradient exceeded 20 mmHg. Based on those measurements, the study population was divided into subgroups with residual aortic stenosis \[AoD(+)\] and without it \[AoD(−)\] \[[@CR17]\].

A clinical characteristics of patients with recoarctation as well as patients without residual stenosis in the AoD (both demographic and biochemical data) is presented in Table [3](#Tab3){ref-type="table"}.

Flow mediated dilatation {#Sec3}
========================

The examination was performed between 8 and 10 a.m. in a temperature-controlled room (20°--22°C) with subjects resting in a supine position. Conduit-vessel endothelial function was assessed using the ultrasound measurement of brachial artery diameter (Bad) during changes in brachial artery flow (7--12 MHz linear array transducer, Logic 7, GE). A 5-cm length of the brachial artery was imaged in a longitudinal section above the antecubital fossa and with the optimal probe site marked on the skin. Baseline images of Bad and Doppler velocities from the center of the vessel were recorded. A distal-occluding forearm cuff placed just below the antecubital fossa was inflated to 50 mmHg above the systolic pressure for 5 min. A brachial artery scan was then obtained for 120 s after the cuff deflation, including a repeated flow velocity recording for the first 15 s after the cuff release. After 10 min of rest, sublingual nitroglycerin (0.5 mg) was administrated to determine the maximum obtainable exogenous vasodilatatory response. Bad and blood flow were measured following NTG. The response of the vessel diameter to reactive hyperemia \[flow-mediated dilatation (FMD)\] was calculated and expressed as the percentage change relative to the diameter measured immediately before the cuff inflation. The diameter change caused by nitroglycerin was expressed as the percentage change relative to the recovery scan \[nitroglycerin-mediated dilatation (NMD)\] \[[@CR12]\].

IMT B-mode carotid ultrasound {#Sec4}
=============================

Carotid scans were performed using a Logic 7, GE ultrasound machine with the 7--12 MHz transducer. Following the acquisition of the scan, the diastolic images with the best demonstrated intimal medial thickening (IMT) were analysed. Both near and far walls of the common carotid artery were visualised on the same scan to ensure the transducer was transecting the artery at 90°. Scans were read by a single observer blinded to the other results. Images were analysed using a quantitative analysis package (Siemens) giving an axial resolution of 0.001 mm. Measurements of IMT were made at 1 mm intervals over a 10 mm segments of the vessel. The maximal and mean IMT measurements were determined for the near and far walls of the left and right common carotid arteries \[[@CR1]\].

Pulse wave velocity {#Sec5}
===================

For the assessment of the pulse wave velocity (PWV), the pulse wave was obtained over the right radial artery and at the neck for the right common carotid artery. Transit time was measured as the time between the foot of the pulse wave and the *R* wave in concurrently recorded ECG. The data were collected directly into the laptop (HP Pavillion Entertainment PC). Pulse transit time was determined as the average of consecutive beats during the last 10 s. Time delay (*t*) was calculated as the difference between those two transit times. The distance (*d*) travelled by the pulse wave was measured over the body surface at the distance between the two locations. Pulse wave velocity was calculated as PWV = *d*/*t* m/s by the SphygmoCor device (SphygmoCor PVx, Version 8.0, AtCor, Sydney, Australia) \[[@CR23]\].

Central aortic function assessment {#Sec6}
==================================

Central parameters of the aortic pulse wave and arterial wall stiffness of the large conduit arteries were measured using pulse wave analysis performed with applanation tonometry (SphygmoCor PVx, Version 8.0, AtCor, Sydney, Australia). Brachial blood pressure (BP) needed for the algorithm of the procedure was measured non-invasively after 15 min of rest in the supine position with Omron 705IT device (Omron Healthcare, Kyoto, Japan). For the assessment of the parameters of the central aortic pulse wave, the pulse waveform of the radial artery was recorded for 10 s. and a radial to aortic transfer function was used to derive the central aortic pulse pressure (APP) waveform from which the aortic systolic pressure (ASP), aortic diastolic pressure (ADP), augmentation pressure (AP) and augmentation index (AI) were determined. The central aortic pulse wave peaks twice. The first peak is caused by ejection of blood from the left ventricle and the second is a result of the wave reflected from the periphery, overlapping the primary one. The AP is the difference between the second and the first peak, and the AI is the ratio of AP to APP expressed as a percentage \[[@CR22]\].

Statistics {#Sec7}
==========

Data are presented as the mean value with standard deviation (±SD). For variables following normal distribution, statistical analysis was performed with the Student *t* test for unpaired samples. For variables not following normal distribution, the Mann--Whitney *U* test was used. To determine the relationship between variables, the Spearmen rank-order or Pearson correlation were analysed. Categorical variables were compared using the chi-square test. Results of *p* \< 0.05 were considered statistically significant.

Informed consent was obtained from each patient, and our study protocol, as approved a priori by our institution's human research committee, conformed to the ethical guidelines set forth by the 1975 Declaration of Helsinki.

Results {#Sec8}
=======

As shown in Table [2](#Tab2){ref-type="table"}, postcoarctectomy patients had significantly elevated values of both peripheral systolic and diastolic resting blood pressure (SBP and DBP), as compared to the control group (140.3 ± 16.7 vs. 125.6 ± 7.0 mmHg; *p* = 0.00001 and 75.2 ± 9.6 vs. 69.9 ± 9.8 mmHg; *p* = 0.002). Values of ASP were also significantly increased (114.9 ± 13.5 vs. 102.4 ± 10.3 mmHg; *p* = 0.0003) but ADP did not differ between the groups (70.7 ± 9.2 vs. 70.2 ± 9.1; *p* = 0.7). Central parameters: APP in the studied group was higher than in the control patients (43.2 ± 11.9 vs. 32.1 ± 9.8 mmHg; *p* = 0.0003), similar results were obtained for AP (9.2 ± 6.0 vs. 4.4 ± 3.6 mmHg; *p* = 0.00002) and AI (20.3 ± 9.6 vs. 13.5 ± 4.3%; *p* = 0.003). Postcoarctectomy subjects had substantially increased arterial stiffness, as shown by higher values of PWV (7.7 ± 1.7 vs. 5.4 ± 0.9 m/s; *p* = 0.003) and IMT (0.63 ± 0.2 vs. 0.51 ± 0.1 mm; *p* = 0.008). Flow-mediated dilatation after hyperemia, as well as endothelium independent vasodilatation (NMD) were significantly impaired in patients, when compared with the controls (4.9 ± 3.4 vs. 8.5 ± 2.3%; *p* = 0.00005 and 10.6 ± 5.2 vs. 19.8 ± 7.2%; *p* = 0.00001).Table 2Vascular characteristics of the entire study population, normotonic coarctation repair patients and comparison to the control groupCoAo (*N* = 85)CoAo AH(−)\
(*N* = 47)Controls\
(*N* = 30)*p* CoAo versus controls*p* CoAo AH(−) versus controlsHR (beats/min)70.6 ± 11.870.5 ± 9.269.4 ± 10.40.20.2SBP at rest (mmHg)140.3 ± 16.7125.5 ± 9.2120.6 ± 7.00.000010.45DBP at rest (mmHg)75.2 ± 9.673.3 ± 9.969.9 ± 9.80.0020.35ASP (mmHg)114.9 ± 13.5110.8 ± 10.8102.4 ± 10.30.00030.0005ADP (mmHg)70.7 ± 9.270.5 ± 8.770.2 ± 9.10.70.95APP (mmHg)43.2 ± 11.939.6 ± 8.832.1 ± 9.80.000010.0001AP (mmHg)9.2 ± 6.07.3 ± 4.64.4 ± 3.60.000020.002AI (%)20.3 ± 9.618.6 ± 10.413.5 ± 4.30.00020.03PWV (m/s)7.7 ± 1.76.8 ± 1.25.4 ± 0.90.00030.03IMT (mm)0.63 ± 0.20.51 ± 0.10.51 ± 0.10.0080.06FMD (%)4.9 ± 3.44.8 ± 2.88.5 ± 2.30.000050.00003NTG (%)10.6 ± 5.211.3 ± 4.619.8 ± 7.20.000010.00001*CoAo* patients after coarctation repair, *CoAo AH*(*−*) normotonic coarctation repaired patients, *HR* heart rate, *SBP* systolic blood pressure, *DBP* diastolic blood pressure, *ASP* central systolic pressure, *ADP* central diastolic pressure, *APP* central pulse pressure, *AP* augmentation pressure, *AI* augmentation index, *PWV* pulse wave velocity, *IMT* intima-media thickness, *FMD* flow-mediated dilatation, *NMD* nitroglycerin-mediated vasodilatation

Forty-seven patients after CoAo repair had normal blood pressure \[CoAo AH(−)\]. Comparison with the controls revealed differences in central parameters---APP (39.6 ± 8.8 vs. 32.1 ± 9.8 mmHg; *p* = 0.0001), AP (7.3 ± 4.6 vs. 4.4 ± 3.6 mmHg; *p* = 0.002) and AI (18.6 ± 10.4 vs. 13.5 ± 4.3%; *p* = 0.03) in the studied normotensives were significantly higher than among controls. Peripheral vessel parameter analysis showed that PWV of CoAo AH(−) patients was higher than in the control group (6.8 ± 1.2 vs. 5.4 ± 0.9 m/s; *p* = 0.003), but IMT was comparable (0.53 ± 0.1 vs. 0.51 ± 0.1 mm; *p* = 0.06). The studied group revealed lesser degree of vasodilatation as expressed in values of FMD (4.8 ± 2.8 vs. 8.5 ± 2.3%; *p* = 0.00003) and NMD (11.3 ± 4.6 vs 19.8 ± 7.2%; *p* = 0.00001).

Residual stenosis of the AoD was found in 46 patients \[AoD(+)\], their pressure gradient ranged from 20.0 to 70.0 mmHg (mean 35.3 ± 11.9 mmHg), and systolic arm to leg gradient from 20 to 61 mmHg (mean 36.7 ± 13.9 mmHg). In the remaining 39 patients \[AoD(−)\], the pressure gradient ranged from 4.0 to 19.0 mmHg (mean 16.2 ± 6.1 mmHg) and systolic arm to leg gradient respectively, −4 to 17 mmHg (4.8 ± 8.6 mmHg). Demographic characteristics of analysed groups of patients are presented in Table [3](#Tab3){ref-type="table"}. AoD(+) patients were matched for age (35.5 ± 10.4 vs. 33.8 ± 10.4 years; *p* = 0.54) and number of smokers (8.6 vs. 5.1%; *p* = 0.69). There was also no difference between the groups in BMI (25.0 ± 3.0 vs. 26.6 ± 3.6 kg/m^2^; *p* = 0.08), weight (75.5 ± 11.5 vs. 73.2 ± 12.5 kg; *p* = 0.67), height (173.5 ± 8.6 vs. 170.8 ± 9.5 cm; *p* = 0.48), neither in the biochemical parameters. The only parameter differing between the groups was the age at the time of surgical procedure---AoD(−) patients were operated on earlier than AoD(+) patients (12.4 ± 7.9 vs. 9.4 ± 8.0 years; *p* = 0.04).Table 3Baseline characteristics and comparison of patients with respect to the presence of recoarctationAoD(+)\
(*N* = 46)AoD(−)\
(*N* = 39)*p* AoD(+) versus AoD(−)Male:female20:1633:160.24Age (years)33.5 ± 10.435.8 ± 10.40.54Age at surgery (years)12.4 ± 7.99.4 ± 8.00.04Smoker (current)4 (8.6%)2 (5.1%)0.64BMI (kg/m^2^)25.0 ± 3.025.6 ± 3.60.08Height (cm)173.5 ± 8.6170.8 ± 9.50.48Weight (kg)75.5 ± 11.573.2 ± 12.50.67Glucose (mmol/l)5.3 ± 0.65.2 ± 0.60.13Creatinine (umol/l)76.9 ± 13.172.2 ± 12.20.32Total cholesterol (mmol/l)5.2 ± 0.95.4 ± 0.70.91LDL-cholesterol (mmol/l)2.9 ± 0.83.0 ± 0.70.78HDL-cholesterol(mmol/l)1.3 ± 0.21.4 ± 0.40.83Triglycerides (mmol/l)1.3 ± 0.51.5 ± 0.90.79

As shown in Table [4](#Tab4){ref-type="table"}, resting SBP and DBP did not differ between the subgroups with and without residual gradient in the AoD (143.3 ± 14.7 vs. 136.6 ± 14.9 mmHg; *p* = 0.06 and 81.2 ± 9.3 vs. 79.1 ± 10.1 mmHg; *p* = 0.99), as well as the number of patients with hypertension (40.5 vs. 47.9%, *p* = 0.64). Central parameters: comparing patient groups AoD(+) and AoD(−) showed that ASP was higher in patients with recoarctation but this elevation did not reach statistical significance (116.3 ± 14.2 vs. 111.0 ± 12.0 mmHg; *p* = 0.05), while ADP did not differ between the groups (72.6 ± 9.9 vs. 69.3 ± 9.9 mmHg; *p* = 0.09). APP as well as AP were higher in patients with recoarctation (46.7 ± 13.8 vs. 38.3 ± 6.9; *p* = 0.001 and 10.5 ± 6.9 vs. 7.5 ± 4.1; *p* = 0.02). Such difference was not observed comparing AI (21.0 ± 8.8 vs. 19.3 ± 8.5%; *p* = 0.44). Variables concerning arterial stiffness PWV and IMT (7.6 ± 1.3 vs. 7.8 ± 2.0 m/s; *p* = 0.49 and 0.67 ± 0.2 vs. 0.64 ± 0.1 mm; *p* = 0.45) were compared between both subgroups. There were no differences in endothelium dependent-vasodilatation (FMD), as well as endothelium independent vasodilatation (NMD) (4.5 ± 3.2 vs. 5.2 ± 3.4%; *p* = 0.06 and 10.5 ± 5.2 vs. 10.8 ± 5.0%; *p* = 0.75).Table 4Vascular characteristics and comparison of patients with respect to the presence of recoarctationAoD(+)\
(*N* = 46)AoD(−)\
(*N* = 39)*p* AoD(+) versus AoD(−)HR (beats/min)69.8 ± 13.471.6 ± 6.70.47SBP (mmHg)143.3 ± 14.7136.6 ± 14.90.06DBP (mmHg)81.2 ± 9.379.1 ± 10.10.99Hypertonics (%)4 (8.6%)2 (5.1%)0.69ASP (mmHg)116.3 ± 14.2110.0 ± 12.00.05ADP (mmHg)72.6 ± 9.969.3 ± 9.90.09APP (mmHg)46.7 ± 13.838.3 ± 6.90.001AP (mmHg)10.5 ± 6.97.5 ± 4.10.02AI (%)21.0 ± 8,519.3 ± 8.50.44PWV (m/s)7.6 ± 1.37.8 ± 2.00.49IMT (mm)0.67 ± 0.20.64 ± 0.10.45FMD (%)4.6 ± 3.25.1 ± 3.90.06NTG (%)10.5 ± 5.210.8 ± 5.00.75*CoAo* patients after coarctation repair, *CoAo AH*(−) normotonic coarctation repaired patients, *HR* heart rate, *SBP* systolic blood pressure, *DBP* diastolic blood pressure, *ASP* central systolic pressure, *ADP* central diastolic pressure, *APP* central pulse pressure, *AP* augmentation pressure, *AI* augmentation index, *PWV* pulse wave velocity, *IMT* intima-media thickness, *FMD* flow-mediated dilatation, *NMD* nitroglycerin-mediated vasodilatation

Linear correlation analysis of results for the entire study group concerning current age, age at the operation, gradient across the AoD and analysed vascular parameters showed significant positive correlation between current age and APP (*r* = 0.361; *p* = 0,001), AP (*r* = 0.444; *p* = 0.00002), as well as AI (*r* = 0.481; *p* = 0.00001). Gradient across the AoD correlated positively with AP (*r* = 0.295; *p* = 0.01). There was no significant linear correlation between age at the time of surgery and any of peripheral arterial parameters (Table [5](#Tab5){ref-type="table"}).Table 5Correlations between arterial parameters and current age, age at the operation and gradient across the descending aortaCurrent ageAge at operationAoD gradientAPP*p* = 0.001NSNS*r* = 0.3605AP*p* = 0.00007NS*p* = 0.01*r* = 0.4443*r* = 0.259AI*p* = 0.00007NSNS*r* = 0.617FMDNSNSNSNMDNSNSNSIMTNSNSNSPWVNSNSNS*APP* aortic pulse pressure, *AP* augmentation pressure, *AI* augmentation index, *PWV* pulse wave velocity, *IMT* intima-media thickness, *FMD* flow-mediated dilatation, *NMD* nitroglycerin-mediated vasodilatation

Discussion {#Sec9}
==========

Long-term follow-up shows that despite successful repair, post-CoAo subjects are at high risk of AH and subsequent end-organ complications \[[@CR7], [@CR12], [@CR24], [@CR25]\]. An important pathogenetic link between these phenomena are changes in arterial morphology and reactivity \[[@CR2], [@CR3], [@CR12], [@CR19], [@CR22], [@CR24], [@CR26]--[@CR32]\]. It still remains to be unresolved, whether vascular remodeling is an inherent part of this congenital condition or results from increased blood pressure values \[[@CR10], [@CR21], [@CR33]\]. Gidding et al. \[[@CR34]\] were first to show enhanced vasoconstriction of the forearm arteries of CoAo patients, with no such response in the vessels of the lower part of the body, and that confirmed functional and morphological autonomy of the precoarctation arterial tree. Our study confirms presence of advanced vascular pathology in this group of patients. To eliminate the influence of hypertension as a causative factor, the analysis was limited to data obtained from normotensive subjects. As described by the majority of authors \[[@CR2], [@CR12], [@CR22], [@CR24], [@CR26]--[@CR28], [@CR30]\], in this population of patients reduced responses are present of both, endothelium dependent arterial relaxation (FMD) in the brachial artery and nitroglycerine-mediated vasodilatation (NMD) reflecting depleted diastolic capability due to reduced capacity for relaxation of vascular smooth muscle cells or structural changes in the arterial wall. Increased stiffness of precoarctation arteries in postcoarctectomy patients is confirmed by higher values of PWV found in our study, a parameter which is considered to be a robust index of arterial stiffness. Similar conclusions were drawn by both de Divitiis et al. \[[@CR12]\] and Ou et al. \[[@CR9]\]. On the other hand, our study found no differences in intima-media thickness (IMT), which corresponds to results of Swan et al. \[[@CR1]\], but was not confirmed by others \[[@CR17], [@CR24]\]. What is more, Meyer et al. \[[@CR2]\] reported significantly higher IMT in children, which may validate congenital character of vascular changes in CoAo. It is important, that the pathological values of peripheral vascular parameters in the study are established risk factors for serious cardiovascular events (stroke, coronary artery disease, general cardiac mortality) \[[@CR35], [@CR36]\]. Similar prognostic value was determined for both AP and AI---indicators of increased ASP, reflecting total vascular stiffness \[[@CR37]\]. Our study point towards a significant increase in those parameters in patients after CoAo repair, which was also previously reported by Chen et al. \[[@CR22]\]. Swan et al. \[[@CR1]\] reported that only values of central arterial pulse pressure (APP) were higher than in the healthy population. Those authors underline the usefulness of central vascular parameters---facilitating early evaluation of the risk of potential subendocardial ischemia in the left ventricle, resulting from early returned arterial wave, following increased stiffness of precoarctation arterial tree \[[@CR1], [@CR21]\]. Our analysis confirms the thesis that vascular remodeling in patients after CoAo repair is a phenomenon independent of AH \[[@CR3], [@CR10], [@CR21], [@CR22], [@CR26]\]. The majority of scientists in that field claim that intrinsic abnormalities of the aortic wall and functional abnormalities in vascular reactivity may lead to hypertension and simultaneously positive feedback can be provided by hypertension itself by enhancing this remodeling \[[@CR3], [@CR10], [@CR14], [@CR22]\].

There is no agreement on the role of residual gradient in the AoD. Although some researchers report that recoarctation influences value of blood pressure \[[@CR17], [@CR38]\], still most authors find no association between AH and discreet residual aortic narrowing \[[@CR3], [@CR8], [@CR11], [@CR12]\], which stands in line with the results achieved in our analysis. We have found no association between AH and discreet residual aortic narrowing. The results of our study revealed no significant differences in stiffness and reactivity parameters between patients with and without recoarctation. Moreover, there have been no relevant correlations between those parameters and transaortic gradient. Meyer et al. \[[@CR2]\] also reported no link between peripheral arterial reactivity and the level of recoarctation in children operated for CoAo. On the other hand, our patients with residual AoD gradient showed higher values of augmentation and central pulse pressure. The results of those parameters point to increased aortic wall stiffness as well as abnormal wave transmission. In healthy individuals with normal aorta, reflected wave comes only from distal vasculature, while after CoAo repair pressure waves are reflected not only from the distal part of the vascular bed but also proximally---from the site of obstruction \[[@CR1], [@CR22]\]. This phenomenon could be partly responsible for increase in the values of central parameters revealed in patients with recoarctation, as well as an important link between AP and transaortic gradient. Observed in our study, lack of correlation between the residual narrowing of AoD and parameters of peripheral remodeling confirms the thesis that hypertension in CoAo patients is not associated with a mechanical obstruction but rather with the primary stiffness of proximal aortic segment, resulting from an increase in collagen and a decrease in smooth muscle cells present in the aortic wall \[[@CR3], [@CR9], [@CR10], [@CR19], [@CR32]\]. The reduced elastic properties of the precoarctation aorta lead to permanent abnormalities in baroreceptor readaptation \[[@CR3], [@CR9], [@CR10], [@CR21], [@CR29], [@CR39]\]. Although Vriend et al. \[[@CR17]\] claim that interventional dilatation should be performed even in case of small residual narrowing of AoD, Chen et al. \[[@CR22]\] have not shown any improvement in the peripheral arterial remodeling parameters in patients following stent implantation at the site of stenosis, which in turns seems to support the results obtained in our study.

Undoubtedly, CoAo repair significantly improved prognosis of patients with this congenital heart disease and long-term observation reveal that prevalence of hypertension and overall mortality depend on the age at the time of surgery \[[@CR5], [@CR13], [@CR14], [@CR22], [@CR33]\]. However, an increasing number of researchers support the thesis that even an early operation may not alter the course of this cardiovascular disease and will not prevent harmful vascular changes in those patients \[[@CR10], [@CR21]\]. Our analysis revealed no relationship between age at the operation and arterial reactivity expressed as FMD and NMD, which confirms earlier findings \[[@CR2], [@CR12], [@CR26]\]. Heger et al. \[[@CR27]\] claim that higher FMD and NMD were observed in patients operated on before the age of nine but at the same time they report no significant correlation of those parameters with the age at the surgery. On the contrary to de Divitiis et al. \[[@CR12]\], our study failed to identify the link between PWV and IMT or age at the operation. These observations suggest early determination of vascular changes in CoAo patients, the mechanism which is likely dependent on potential genetic or intrauterine factors \[[@CR21], [@CR40]\].

Our study showed that parameters related to central pressure pulse wave---AP, AI and APP---do correlate with the current age of patients, which is true in general for the aging population \[[@CR35]\], but they do not display any relationship to the age at the surgery. Increased compliance of precoarctation aorta after removal of mechanical obstruction was clearly obtained by Brili et al. \[[@CR29]\]. Yet, Vogt et al. \[[@CR32]\] report impaired elastic properties of the ascending aorta even in newborns after successful CoAo repair. It seems that even though central parameters are related to increased general arterial stiffness, pathologic changes characteristic for ascending aorta in CoAo are themselves an important independent determinant of vascular remodeling \[[@CR10], [@CR20]\]. That validates the claim that despite early successful repair permanent impairment of vascular compliance above the place of coarctation might be the cause of vascular and end-organ complications.

Conclusions {#Sec10}
===========

Residual stenosis in the AoD does not affect the arterial vasodilatation nor stiffness in patients after CoAo repair. Early operation has no impact on peripheral vascular remodeling or central pressure which supports the claim that coarctation of the aorta is a systemic vascular disorder which leads to progressive vascular and end-organ damage despite early correction.
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